P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial

Bibliographic Details
Main Authors: N. Hoefnagels, A. Gautier, A. Müller, S. Schär, L. Rosset, N. Corke Mahbiz, M. Schwitter, U. Güth, A. Jakob, C. Balmelli-Cattelan, C. Leo, M. Fehr, D.R. Thorn, S. Riniker, A. Chouiter-Djebaili, J. Musilova, F. Honecker
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623003867
_version_ 1797869876178583552
author N. Hoefnagels
A. Gautier
A. Müller
S. Schär
L. Rosset
N. Corke Mahbiz
M. Schwitter
U. Güth
A. Jakob
C. Balmelli-Cattelan
C. Leo
M. Fehr
D.R. Thorn
S. Riniker
A. Chouiter-Djebaili
J. Musilova
F. Honecker
author_facet N. Hoefnagels
A. Gautier
A. Müller
S. Schär
L. Rosset
N. Corke Mahbiz
M. Schwitter
U. Güth
A. Jakob
C. Balmelli-Cattelan
C. Leo
M. Fehr
D.R. Thorn
S. Riniker
A. Chouiter-Djebaili
J. Musilova
F. Honecker
author_sort N. Hoefnagels
collection DOAJ
first_indexed 2024-04-10T00:19:25Z
format Article
id doaj.art-ff6ea95cc8a04589acc07151d6d692b6
institution Directory Open Access Journal
issn 1532-3080
language English
last_indexed 2024-04-10T00:19:25Z
publishDate 2023-03-01
publisher Elsevier
record_format Article
series Breast
spelling doaj.art-ff6ea95cc8a04589acc07151d6d692b62023-03-16T05:02:50ZengElsevierBreast1532-30802023-03-0168S122S123P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trialN. HoefnagelsA. GautierA. MüllerS. SchärL. RossetN. Corke MahbizM. SchwitterU. GüthA. JakobC. Balmelli-CattelanC. LeoM. FehrD.R. ThornS. RinikerA. Chouiter-DjebailiJ. MusilovaF. Honeckerhttp://www.sciencedirect.com/science/article/pii/S0960977623003867
spellingShingle N. Hoefnagels
A. Gautier
A. Müller
S. Schär
L. Rosset
N. Corke Mahbiz
M. Schwitter
U. Güth
A. Jakob
C. Balmelli-Cattelan
C. Leo
M. Fehr
D.R. Thorn
S. Riniker
A. Chouiter-Djebaili
J. Musilova
F. Honecker
P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
Breast
title P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
title_full P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
title_fullStr P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
title_full_unstemmed P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
title_short P268 Impact of the 2020 COVID-19 lockdown in Switzerland on physical activity in patients with early breast cancer under aromatase-inhibitor therapy. A subanalysis of the SAKK 95/17 WISE trial
title_sort p268 impact of the 2020 covid 19 lockdown in switzerland on physical activity in patients with early breast cancer under aromatase inhibitor therapy a subanalysis of the sakk 95 17 wise trial
url http://www.sciencedirect.com/science/article/pii/S0960977623003867
work_keys_str_mv AT nhoefnagels p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT agautier p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT amuller p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT sschar p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT lrosset p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT ncorkemahbiz p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT mschwitter p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT uguth p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT ajakob p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT cbalmellicattelan p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT cleo p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT mfehr p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT drthorn p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT sriniker p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT achouiterdjebaili p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT jmusilova p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial
AT fhonecker p268impactofthe2020covid19lockdowninswitzerlandonphysicalactivityinpatientswithearlybreastcancerunderaromataseinhibitortherapyasubanalysisofthesakk9517wisetrial